Alex Denner (Photo by: Mark Neuling/CNBC/NBCU Photo Bank via Getty Images)
March 22, 2022 12:18 PM EDT
People
Pharma

Hunt for Russ­ian oli­garch’s bil­lions leads to biotech ac­tivist in­vestor Alex Den­ner’s fund — re­port

John Carroll

Editor & Founder

The glob­al drag­net be­ing thrown out to cap­ture bil­lions of dol­lars in Russ­ian oli­garch mon­ey has spot­light­ed the role of an ac­tivist in­vestor who’s spurred …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times